SLC22A2 and renal cell adenocarcinoma: Pretreatment of RCC cell lines with decitabine increased oxaliplatin cellular accumulation and resulted in a multifold decrease in IC50. This effect did not take place in modified RCC cell lines after OCT2 knocking down.